Can-Fite Biopharma Overview

Can-Fite Biopharma Gross Profit

Gross Profit analysis for CANF.

Quarterly Gross Profit

$101000.00

↓ 36.08% YoY

As of Jun 30, 2025

Annual Gross Profit (TTM)

$560000.00

↓ 16.04% YoY

Trailing 12 months ending Jun 30, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin